Evidence map›Paper›PMID 40202141›Full record

Trial reportJournal of cosmetic dermatology2025

Efficacy and Skin Acceptability of a Cosmetic Cream for Nasolabial Dryness and Irritation.

Constance Prime, William Hooper, Yosra Ghrib Ben Sassi, Nejib Doss, Oliver Chen

Abstract readClinical Trial
In one paragraph

Trial report in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Constance PrimeSofibel-Church & Dwight, Levallois-Perret, France.
William HooperChurch & Dwight, Princeton, New Jersey, USA.
Yosra Ghrib Ben SassiEurofins, Dermscan, Ariana, Tunisie.
Nejib DossEurofins, Dermscan, Tunis, Tunisie.
Oliver ChenChurch & Dwight, Princeton, New Jersey, USA.

Funding

Church and Dwight
6 · The paper itself

Abstract

introductionRhinorrhea is a widespread condition related to common upper respiratory insults such as influenza and rhinitis, often accompanied by frequent nose cleansing resulting in skin irritation. This study evaluated the cutaneous acceptability and nourishing, soothing, protecting, and moisturizing effects of Sterimar Soothing Nose Cream on the skin around the nose in healthy adults.

methodsWe conducted an exploratory single-arm clinical trial in 33 adults (mean age 46 years) who blow their nose often (> 5 times/day) due to a cold or allergies and have sensitive, irritated/dry nose. Participants applied the cream topically on their noses twice daily for 14 days. Cutaneous acceptability and efficacy measures were assessed by participants and by the study dermatologist before, during, and after 14 days. Skin imaging analysis via the Visia camera system and skin hydration via Corneometer were also assessed. Participants also completed a questionnaire about overall product performance.

resultsThe dermatologist noted reduced (p < 0.001) redness, swelling, dryness, roughness, and itchiness, with improved (p < 0.001) hydration, softness, and flexibility after 7 and 14 days. Participants reported less (p < 0.05) dryness, redness, and discomfort, with 97% rating the cream's soothing effect as moderate to strong. The cream also increased (p < 0.0001) skin hydration by 14%, measured by Corneometer 30 min postapplication. No worsening of symptoms or adverse effects was reported. All participants found the cream pleasant, with most intending to purchase and continue use.

conclusionsThe results indicate that Sterimar soothing nose cream is effective in nourishing, soothing, protecting, and moisturizing the nasolabial zone, and is well tolerated.

Indexed as

Skin CreamAdministration, CutaneousAdultFemaleHumansMaleMiddle AgedPatient SatisfactionSkinTreatment OutcomeYoung Adultfacial skinnasal irritationrepairrhinorrheaskin barrierskincaretopical

Identifiers

PMID40202141
PMCPMC11980023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.